Lymphoma Clinical Trials

Showing 1761-1780 of 2,926 trials

Tumor Registry of Lymphatic Neoplasia

NCT00889798

The purpose of this registry is to record information on therapy reality of malignant lymphatic systemic diseases by office-based haematologists in Germany.

Non-Hodgkin's Lymphoma (NHL)Chronic Lymphocytic Leukemia (CLL)Multiple Myeloma (MM)

iOMEDICO AG3,795 participantsStarted Apr 2009

TERMINATEDPhase 2

Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

NCT00303719

RATIONALE: A peripheral stem cell transplant may be able to replace blood-forming cells that were destroyed by chemotherapy and radiation therapy, or that have become cancer. Sometimes the transplanted cells from a donor can make an immune response against the body's normal cells. Giving cyclophosphamide and fludarabine together with total-body irradiation followed by cyclosporine and mycophenolate mofetil before the transplant may stop this from happening. PURPOSE: This clinical trial is studying how well giving combination chemotherapy together with radiation therapy followed by cyclosporine and mycophenolate mofetil works in treating patients who are undergoing a donor stem cell transplant for hematologic cancer, metastatic breast cancer, or kidney cancer.

Kidney CancerLeukemiaLymphoma+3 more

Masonic Cancer Center, University of Minnesota342 participantsStarted Mar 2002

Minneapolis, Minnesota, United States

Tumor Registry of Lymphatic Neoplasia

Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

Related Searches

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

A Study of YY-20394 in Participants With Relapsed/Refractory Follicular Non-Hodgkin's Lymphoma

Sintilimab and Decitabine for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma

Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)

Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product

Positron Nuclide Labeled NOTA-FAPI PET Study in Lymphoma

Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS)

Chidamide Combination With Lenalidomide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Pembrolizumab and Total Skin Electron Beam Radiotherapy in Mycosis Fungoides and Sézary Syndrome

Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR

Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation

Thiopurine EnhAnced Maintenance Therapy

Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies

Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment

HD17 for Intermediate Stage Hodgkin Lymphoma

Treatment for Chronic Pain in Patients With Advanced Cancer

Radiation Therapy in Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation